TY - JOUR
T1 - Identification of clinically relevant multi-drug resistant ESKAPEE isolates from hospital wastewater surveillance in Thailand
AU - Chaudhury, Sidhartha
AU - Oransathit, Wilawan
AU - Peerapongpaisarn, Dutsadee
AU - Oransathit, Wirote
AU - Thamnurak, Chatchadaporn
AU - Pradipol, Chantida
AU - Kirativanich, Kirakarn
AU - Ruekit, Sirigade
AU - Boonsiri, Tanit
AU - Thanyathada, Yutthana
AU - Sapre, Anjali P.
AU - Bartlett, Katelyn V.
AU - Martin, Melissa J.
AU - Lertsethtakarn, Paphavee
AU - Vanachayangkul, Pattaraporn
AU - Livezey, Jeffrey R.
AU - Boudreaux, Daniel M.
AU - Ruamsap, Nattaya
N1 - Publisher Copyright:
Copyright © 2025 Chaudhury, Oransathit, Peerapongpaisarn, Oransathit, Thamnurak, Pradipol, Kirativanich, Ruekit, Boonsiri, Thanyathada, Sapre, Bartlett, Martin, Lertsethtakarn, Vanachayangkul, Livezey, Boudreaux and Ruamsap.
PY - 2025
Y1 - 2025
N2 - Introduction: Wastewater surveillance has recently emerged as a promising method for AMR surveillance, but few studies have directly compared wastewater surveillance samples with clinical isolates and the clinical significance of wastewater surveillance for AMR bacteria is still unclear. Methods: We carried out monthly surveillance of hospital wastewater and surrounding community water at a tertiary hospital in Chonburi, Thailand from March to December 2024 and compared our findings with clinical isolates collected at the same hospital during the same period. For each wastewater sample, we isolated ESKAPEE pathogens, identified species by mass spectrometry, performed antimicrobial susceptibility testing (AST), followed by PCR testing of AMR genes and whole genome sequencing (WGS) on a subset of wastewater isolates and compared our results to clinical isolates. Results: We obtained 2,735 AMR isolates from untreated hospital wastewater, of which 1,550 were ESKAPEE pathogens including: Klebsiella pneumoniae (35.8%), Enterobacter spp. (397, 25.6%), Escherichia coli (24.9%), Enterococcus faecium (10.1%), Acinetobacter baumannii (2.7%), and Pseudomonas aeruginosa (0.8%). Based on AST data, we found that 85% K. pneumoniae isolates, 43% A. baumannii isolates, and 98% E. coli isolates, 62% Enterobacter spp. isolates, and 26% E. faecium isolates were classified as multi-drug resistant. We carried out hierarchical clustering of the AST data for a subset of 416 wastewater isolates along with 743 clinical isolates and found significant overlap in AST profiles of wastewater and clinical isolates. Using the clustering data, we selected a subset of 52 wastewater isolates with similar AST profiles to clinical isolates for WGS and identified 19 wastewater isolates that were highly genetically related (≤10 different alleles by cgMLST) to a clinical isolate, including 9 isolates with zero different alleles from closely related clinical isolates. Conclusion: Our results show that surveillance of untreated hospital wastewater is capable of identifying ESKAPEE that share similar drug resistance profiles, AMR genes, and clonal lineages found in the clinical isolates over the same time period. To our knowledge, this is one of the first studies to demonstrate a high level of genetic-relatedness between hospital wastewater and clinical isolates and demonstrate the clinical relevance of bacterial wastewater surveillance for MDR ESKAPEE pathogens.
AB - Introduction: Wastewater surveillance has recently emerged as a promising method for AMR surveillance, but few studies have directly compared wastewater surveillance samples with clinical isolates and the clinical significance of wastewater surveillance for AMR bacteria is still unclear. Methods: We carried out monthly surveillance of hospital wastewater and surrounding community water at a tertiary hospital in Chonburi, Thailand from March to December 2024 and compared our findings with clinical isolates collected at the same hospital during the same period. For each wastewater sample, we isolated ESKAPEE pathogens, identified species by mass spectrometry, performed antimicrobial susceptibility testing (AST), followed by PCR testing of AMR genes and whole genome sequencing (WGS) on a subset of wastewater isolates and compared our results to clinical isolates. Results: We obtained 2,735 AMR isolates from untreated hospital wastewater, of which 1,550 were ESKAPEE pathogens including: Klebsiella pneumoniae (35.8%), Enterobacter spp. (397, 25.6%), Escherichia coli (24.9%), Enterococcus faecium (10.1%), Acinetobacter baumannii (2.7%), and Pseudomonas aeruginosa (0.8%). Based on AST data, we found that 85% K. pneumoniae isolates, 43% A. baumannii isolates, and 98% E. coli isolates, 62% Enterobacter spp. isolates, and 26% E. faecium isolates were classified as multi-drug resistant. We carried out hierarchical clustering of the AST data for a subset of 416 wastewater isolates along with 743 clinical isolates and found significant overlap in AST profiles of wastewater and clinical isolates. Using the clustering data, we selected a subset of 52 wastewater isolates with similar AST profiles to clinical isolates for WGS and identified 19 wastewater isolates that were highly genetically related (≤10 different alleles by cgMLST) to a clinical isolate, including 9 isolates with zero different alleles from closely related clinical isolates. Conclusion: Our results show that surveillance of untreated hospital wastewater is capable of identifying ESKAPEE that share similar drug resistance profiles, AMR genes, and clonal lineages found in the clinical isolates over the same time period. To our knowledge, this is one of the first studies to demonstrate a high level of genetic-relatedness between hospital wastewater and clinical isolates and demonstrate the clinical relevance of bacterial wastewater surveillance for MDR ESKAPEE pathogens.
KW - antimicrobial resistance
KW - carbapenemase
KW - ESBL
KW - ESKAPEE
KW - MDR
KW - one health
KW - Thailand
KW - wastewater
UR - http://www.scopus.com/inward/record.url?scp=105016789864&partnerID=8YFLogxK
U2 - 10.3389/fmicb.2025.1657219
DO - 10.3389/fmicb.2025.1657219
M3 - Article
AN - SCOPUS:105016789864
SN - 1664-302X
VL - 16
JO - Frontiers in Microbiology
JF - Frontiers in Microbiology
M1 - 1657219
ER -